METADATE ER Reviews (METHYLPHENIDATE HYDROCHLORIDE)

Average Rating: 3.0 (1 Ratings)

Filter Results

Compare METADATE ER with similar:
   DEA Schedule II   

 Type: Rx Drug

  

METADATE ER  (METHYLPHENIDATE HYDROCHLORIDE):  This medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. This medication is also used to treat a certain sleep disorder (narcolepsy).   FDA Approval Date: 1999-10-20 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR METADATE ERCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 3  add anxiety, sleeplessness Worked well initially although sometimes seemed unable to focus. Worked better than Concerta which was tried initially-maxed out at 76 mg. Eventually though the Metadate did not seem to control symptoms as spaciness and sleepiness returned even though was on 60 mg. Tried Adderall for a week and was very moody and anxious. Switched to Strattera now and am very, very tired. Taking it at bedtime. So far Metadate the best at least initially. F 13 6 days
8/7/2004
  

METADATE ER  (METHYLPHENIDATE HYDROCHLORIDE):  This medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. This medication is also used to treat a certain sleep disorder (narcolepsy).   FDA Approval Date: 1999-10-20 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP